Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 5,353 shares at $14.47 ($77K) on 2026-02-24, disclosed to the SEC on 2026-02-25.
Scheduled sale ($77k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.99 | 1,752 | $25K | 32.0% |
| 2 | $14.47 | 3,601 | $52K | 68.0% |
| Total | $14.31 avg | 5,353 | $77K | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |